South Africa Bronchodilators Market Size & Outlook

The bronchodilators market in South Africa is expected to reach a projected revenue of US$ 226.4 million by 2030. A compound annual growth rate of 3.1% is expected of South Africa bronchodilators market from 2023 to 2030.
Revenue, 2022 (US$M)
$177.2
Forecast, 2030 (US$M)
$226.4
CAGR, 2023 - 2030
3.1%
Report Coverage
South Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa bronchodilators market, 2018-2030 (US$M)

South Africa bronchodilators market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa bronchodilators market highlights

  • The South Africa bronchodilators market generated a revenue of USD 177.2 million in 2022 and is expected to reach USD 226.4 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 3.1% from 2023 to 2030.
  • In terms of segment, beta-adrenergic bronchodilators was the largest revenue generating drug class in 2022.
  • Beta-Adrenergic Bronchodilators is the most lucrative drug class segment registering the fastest growth during the forecast period.


Bronchodilators market data book summary

Market revenue in 2022USD 177.2 million
Market revenue in 2030USD 226.4 million
Growth rate3.1% (CAGR from 2022 to 2030)
Largest segmentBeta-adrenergic bronchodilators
Fastest growing segmentBeta-Adrenergic Bronchodilators
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBeta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives
Key market players worldwideGSK PLC, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Mylan, Merck KGaA, Merck & Co Inc, Novartis AG ADR, Boehringer Ingelheim, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.8% of the global bronchodilators market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia bronchodilators market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 128.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bronchodilators Market Companies

Name Profile # Employees HQ Website
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
Mylan View profile 10001+ https://www.mylan.in/
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Sun Pharmaceutical Industries View profile 10001+ Mumbai, Maharashtra, India, Asia http://www.sunpharma.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Cipla Ltd DR View profile 38955 Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 https://www.cipla.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

South Africa bronchodilators market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchodilators market will help companies and investors design strategic landscapes.


Beta-adrenergic bronchodilators was the largest segment with a revenue share of 41.14% in 2022. Horizon Databook has segmented the South Africa bronchodilators market based on beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Africa bronchodilators market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa bronchodilators market databook

  • Our clientele includes a mix of bronchodilators market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa bronchodilators market, including forecasts for subscribers. This country databook contains high-level insights into South Africa bronchodilators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa bronchodilators market report size, by drug class, 2018-2030 (US$M)

South Africa Bronchodilators Market Share, 2022 & 2030 (US$M)

South Africa bronchodilators market report size, by drug class, 2018-2030 (US$M)

Related statistics

No records

No related statistics found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online